BioSpace News Archive

Business

A New $550 Million Life Sciences Venture Capital Fund is in Town

venBio Global Strategic Fund IV will invest primarily in drug companies focused on developing therapies for unmet medical needs.

June 3, 2021
·
3 min read
·
Mark Terry
Business

Merck Spinout Launches to Tackle Global Women’s Health Care Problems

Organon’s focus will center on reproductive health, health conditions, and issues unique to women and diseases that disproportionately impact women.

June 3, 2021
·
2 min read
·
Brandon May
Business

BioSpace Movers & Shakers, June 4

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

June 3, 2021
·
9 min read
·
Alex Keown
Drug Development

Novartis Breaks Through with Radioligand Therapy for Prostate Cancer

Today, the Swiss pharma titan announced the results of its Phase III VISION study, where 177Lu-PSMA-617 plus best standard of care (SOC) met both of its primary endpoints.

June 3, 2021
·
4 min read
·
Heather McKenzie
Policy

Pharma on Trial: Multiple Companies are in Legal Crosshairs

AbbVie has been the target of multiple legal inquiries and challenges of its pricing and patent protections. Now, a U.S. senator is taking a gander at the company’s taxes.

June 3, 2021
·
3 min read
·
Alex Keown
Pharm Country

Organon Launches as New Global Women’s Health Company

Launching with a commitment to listen to women to understand her health needs and help identify solutions that are urgently needed

June 3, 2021
·
7 min read
Suction Coagulators Market: Rising Trend of Computer-assisted or Robotic Minimally Invasive Surgery is Expected to Boost the Market

Suction coagulators are used for controlled fluid evacuation. They also provide coagulation and suction procedures simultaneously.

June 3, 2021
·
5 min read
Stem Cell Manufacturing Market Players are Strengthening their Production Capabilities | Here’s Why

Stem cells refer to special cells created by bone marrow of an individual. The key specialty of these cells is their ability to turn into various types of blood cells.

June 3, 2021
·
4 min read
Rare Neurological Disease Treatment Market - Biologic drugs are anticipated to gain a high demand and generate a telling amount of revenue | TMR Research Study

Neurological diseases have affected millions around the globe, and are known to be one of the worst kinds of maladies that can strike absolutely anyone.

June 3, 2021
·
5 min read
Krabbe Disease Treatment Market: Increasing awareness about Krabbe disease to drive the market

Krabbe Disease is an inherited condition that tends to destroy the coatings of the nerve cells (Myelin) in the central nervous system and brain.

June 3, 2021
·
4 min read